SE7501967L - - Google Patents
Info
- Publication number
- SE7501967L SE7501967L SE7501967A SE7501967A SE7501967L SE 7501967 L SE7501967 L SE 7501967L SE 7501967 A SE7501967 A SE 7501967A SE 7501967 A SE7501967 A SE 7501967A SE 7501967 L SE7501967 L SE 7501967L
- Authority
- SE
- Sweden
- Prior art keywords
- contg
- soluble
- capsule
- compsns
- overdosing
- Prior art date
Links
- 239000002775 capsule Substances 0.000 abstract 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 abstract 1
- 229960005156 digoxin Drugs 0.000 abstract 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000003605 opacifier Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44496174A | 1974-02-22 | 1974-02-22 | |
US45300074A | 1974-03-19 | 1974-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7501967L true SE7501967L (en, 2012) | 1975-08-25 |
SE426549B SE426549B (sv) | 1983-01-31 |
Family
ID=27034126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7501967A SE426549B (sv) | 1974-02-22 | 1975-02-21 | Sett att framstella oralt intagbart farmaceutiskt preparat innehallande digoxin |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS50126822A (en, 2012) |
AU (2) | AU501549B2 (en, 2012) |
CA (1) | CA1096307A (en, 2012) |
DE (1) | DE2507635A1 (en, 2012) |
ES (1) | ES434971A1 (en, 2012) |
FI (1) | FI750489A7 (en, 2012) |
FR (1) | FR2261752B1 (en, 2012) |
GB (1) | GB1506016A (en, 2012) |
IE (1) | IE41620B1 (en, 2012) |
IL (1) | IL46682A (en, 2012) |
IT (1) | IT1233251B (en, 2012) |
LU (1) | LU71894A1 (en, 2012) |
NL (1) | NL7502121A (en, 2012) |
SE (1) | SE426549B (en, 2012) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1508770A (en) * | 1974-04-01 | 1978-04-26 | Scherer Ltd R | Pharmaceutical compositions |
US4002718A (en) * | 1974-10-16 | 1977-01-11 | Arnar-Stone Laboratories, Inc. | Gelatin-encapsulated digoxin solutions and method of preparing the same |
DE2805165A1 (de) * | 1977-02-09 | 1978-08-10 | Christiaens Sa A | Gitoxin enthaltendes arzneimittel und verfahren zu seiner herstellung |
IT1158722B (it) * | 1977-07-08 | 1987-02-25 | Simes | Composizione farmaceutica per il trattamento delle turbe del sonno |
JPS5625428U (en, 2012) * | 1979-08-03 | 1981-03-09 | ||
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
SE8203953D0 (sv) * | 1982-06-24 | 1982-06-24 | Astra Laekemedel Ab | Pharmaceutical mixture |
DE3445237C1 (de) * | 1984-12-12 | 1986-06-05 | R.P. Scherer GmbH, 6930 Eberbach | Weichgelatinekapseln und Verfahren zu ihrer Herstellung |
DE3529694A1 (de) * | 1985-08-20 | 1987-02-26 | Scherer Gmbh R P | Gelatinekapseln und verfahren zu ihrer herstellung |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1481411A (en) * | 1973-07-20 | 1977-07-27 | Scherer Ltd R | Pharmaceutical compositions |
-
1975
- 1975-02-21 FI FI750489A patent/FI750489A7/fi not_active Application Discontinuation
- 1975-02-21 ES ES434971A patent/ES434971A1/es not_active Expired
- 1975-02-21 CA CA220,535A patent/CA1096307A/en not_active Expired
- 1975-02-21 NL NL7502121A patent/NL7502121A/xx active Search and Examination
- 1975-02-21 DE DE19752507635 patent/DE2507635A1/de active Granted
- 1975-02-21 JP JP50021803A patent/JPS50126822A/ja active Pending
- 1975-02-21 IL IL46682A patent/IL46682A/xx unknown
- 1975-02-21 LU LU71894A patent/LU71894A1/xx unknown
- 1975-02-21 IE IE371/75A patent/IE41620B1/en unknown
- 1975-02-21 GB GB7327/75A patent/GB1506016A/en not_active Expired
- 1975-02-21 AU AU78440/75A patent/AU501549B2/en not_active Expired
- 1975-02-21 FR FR7505457A patent/FR2261752B1/fr not_active Expired
- 1975-02-21 SE SE7501967A patent/SE426549B/xx not_active IP Right Cessation
-
1979
- 1979-05-28 AU AU47500/79A patent/AU520082B2/en not_active Ceased
-
1983
- 1983-11-28 IT IT8349395A patent/IT1233251B/it active
Also Published As
Publication number | Publication date |
---|---|
IL46682A (en) | 1979-07-25 |
GB1506016A (en) | 1978-04-05 |
FR2261752B1 (en, 2012) | 1978-07-21 |
IE41620B1 (en) | 1980-02-13 |
IT1233251B (it) | 1992-03-24 |
AU520082B2 (en) | 1982-01-14 |
JPS50126822A (en, 2012) | 1975-10-06 |
ES434971A1 (es) | 1977-05-16 |
IT8349395A0 (it) | 1983-11-28 |
DE2507635A1 (de) | 1975-08-28 |
CA1096307A (en) | 1981-02-24 |
AU501549B2 (en) | 1979-06-21 |
IE41620L (en) | 1975-08-22 |
DE2507635C2 (en, 2012) | 1991-07-25 |
AU7844075A (en) | 1976-08-26 |
SE426549B (sv) | 1983-01-31 |
LU71894A1 (en, 2012) | 1975-12-09 |
FR2261752A1 (en, 2012) | 1975-09-19 |
FI750489A7 (en, 2012) | 1975-08-23 |
IL46682A0 (en) | 1975-04-25 |
NL7502121A (nl) | 1975-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES442579A1 (es) | Procedimiento para preparar formulaciones de 1-dopa en uni- dades de dosificacion con revestimiento enterico-efervescen-te. | |
ATE67677T1 (de) | Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten. | |
JPS5587716A (en) | Cardiotonic glycoside containing medicine | |
JPS5225013A (en) | Insulin pharmaceutical for nasal administration | |
EG19642A (en) | A process for the preparation of oral composition for the treatment of inflammatory bowel diseases | |
IT1233251B (it) | Prerarato farmaceutico a base di digossina per ingestione orale | |
ES443910A1 (es) | Procedimiento para la preparacion de derivados de acido ben-zoico. | |
JPS5241214A (en) | Method of making preparations for oral administration | |
CA982478A (en) | Orally administered drug composition for therapy in the treatment of narcotic drug addiction | |
KR850700109A (ko) | 항 이뇨제 ddavp 및 그의 제조 방법 | |
GB1459675A (en) | Method for the prevention of conception | |
IE42950L (en) | X-ray contrast preparations | |
CA2051369A1 (en) | Thyroid hormone cardiac treatment | |
Kramer | Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx.(Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group) | |
MY100780A (en) | Azumolene dosage form. | |
GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
GB1302266A (en, 2012) | ||
ES447712A1 (es) | Un procedimiento de preparacion de una suspension de dioxi- do de titanio. | |
Jaffe et al. | Effects of LSD-25 and dextroamphetamine on speech rhythms in psychotherapy dialogues. | |
GB1429977A (en) | Diuretic composition | |
Böszörményi | Report on Experiences with Ethambutol | |
FR2260995A1 (en) | Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion | |
AU474224B2 (en) | Copolymers of vinyl ethers and cyclic polyenes containing a system of conjugated double bonds and process forthe preparation thereof | |
GB1354643A (en) | Pharmaceutical coating composition | |
JPS62123111A (ja) | 胃内可溶性及び胃抵抗性生薬形態で提供され、消化管の二つのレベルを治療するのに適した非吸収性胃腸薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7501967-9 Effective date: 19910911 Format of ref document f/p: F |